This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
RABBIT ANTI ALK1
catalog :
VPA00702
quantity :
100 µl
price :
346 USD
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot
product information
EntityType :
PrecisionAb Polyclonal
EntityCategory :
Antibodies
ProductCode :
VPA00702
Description :
RABBIT ANTI ALK1
Specificity :
ALK1
TargetSpecies :
Human
Host :
Rabbit
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
WB
ApplicationTypes :
Western Blotting
Quantity :
100 µl
QuantityValue :
100
QuantityType :
ul
GOAccessions :
GO:0001525,GO:0004702,GO:0005887,GO:0046872,GO:0005524,GO:0006468,GO:0007179,GO:0050431,GO:0008217,GO:0008285,GO:0009986,GO:0010596,GO:0016361,GO:0030308,GO:0030513,GO:0035313,GO:0045941,GO:0046332,GO:0048185,GO:0051895
GOTerms :
blood vessel formation from pre-existing blood vessels,receptor signalling protein serine/threonine kinase activity,heavy metal binding,metal binding,protein amino acid phosphorylation,TGFbeta receptor signaling pathway,TGF-beta receptor signaling pathway,TGFbeta receptor signalling pathway,TGF-beta receptor signalling pathway,transforming growth factor beta receptor signalling pathway,TGFbeta binding,TGF-beta binding,transforming growth factor beta ligand binding to type I receptor,transforming growth factor beta ligand binding to type II receptor,blood pressure homeostasis,blood pressure regulation,control of blood pressure,down regulation of cell proliferation,downregulation of cell proliferation,down-regulation of cell proliferation,inhibition of cell proliferation,cell associated,cell bound,GO:0009928,GO:0009929,type I activin receptor activity,down regulation of cell growth,downregulation of cell growth,down-regulation of cell growth,inhibition of cell growth,activation of BMP signaling pathway,positive regulation of BMP receptor signaling pathway,positive regulation of BMP signalling pathway,positive regulation of bone morphogenetic protein signaling pathway,positive regulation of bone morphogenetic protein signalling pathway,stimulation of BMP signaling pathway,up regulation of BMP signaling pathway,upregulation of BMP signaling pathway,up-regulation of BMP signaling pathway,activation of transcription,GO:0061020,positive regulation of cellular transcription,stimulation of transcription,up regulation of transcription,upregulation of transcription,up-regulation of transcription,down regulation of focal adhesion formation,downregulation of focal adhesion formation,down-regulation of focal adhesion formation,inhibition of focal adhesion formation
UniprotAccessions :
P37023
Gene :
ACVRL1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=94
EntityFormats :
Purified
UNSPSC :
41116161
ProductForm :
Purified IgG - liquid
PriceGBP :
262
PriceEUR :
336
PriceUSD :
346 USD
PriceCHF :
366.24
PriceSEK :
3531
PriceNOK :
3599
PriceDKK :
2507
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.